Tumor growth inhibition and regression induced by photothermal vascular targeting and angiogenesis inhibitor retinoic acid

The effect of photothermal vascular targeting, alone and in combination with antiangiogenic therapy, was evaluated using tumors produced in mice by transplantation of KB cells. Tumor growth inhibition and regression followed vascular damage produced by pulsed dye laser (PDL) radiation. Administratio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer letters 1999-03, Vol.137 (1), p.35-44
Hauptverfasser: McMillan, Kathleen, Perepelitsyn, Ilya, Wang, Zhi, Shapshay, Stanley M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 44
container_issue 1
container_start_page 35
container_title Cancer letters
container_volume 137
creator McMillan, Kathleen
Perepelitsyn, Ilya
Wang, Zhi
Shapshay, Stanley M.
description The effect of photothermal vascular targeting, alone and in combination with antiangiogenic therapy, was evaluated using tumors produced in mice by transplantation of KB cells. Tumor growth inhibition and regression followed vascular damage produced by pulsed dye laser (PDL) radiation. Administration of the antiangiogenic agent all- trans-retinoic acid (RA) was associated with smaller average tumor volumes in the presence and absence of PDL irradiation, but this effect was not statistically significant. The ability of PDL photothermal vascular targeting to cause regression of tumors without harming normal tissue may be a consequence of preferential damage to supplying vessels at the tumor periphery.
doi_str_mv 10.1016/S0304-3835(98)00339-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69832940</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304383598003395</els_id><sourcerecordid>69832940</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-458e61a68f95b04821d4eda8b5017e36863601e9f25e8f7e1cebf24669f225cc3</originalsourceid><addsrcrecordid>eNqFkEtv1TAQRi0EoreFnwDyAqGyCNhx_FpVqOIlVWJBWVuOM8k1SuyL7RSVX4_vg8eO1WhG55sZHYSeUfKaEirefCGMdA1TjF9q9YoQxnTDH6ANVbJtpFbkIdr8Qc7Qec7fCCG8k_wxOqOESSF1u0E_b9clJjyl-KNssQ9b3_viY8A2DDjBlCDnfevDsDoYcH-Pd9tYYtlCWuyM72x262wTLjZNUHyYDkkbJh8nCJB9_r21nkl7InqHrfPDE_RotHOGp6d6gb6-f3d7_bG5-fzh0_Xbm8YxTUrTcQWCWqFGzXvSqZYOHQxW9ZxQCUwowQShoMeWgxolUAf92HZC1EnLnWMX6OVx7y7F7yvkYhafHcyzDRDXbIRWrNUdqSA_gi7FnBOMZpf8YtO9ocTspZuDdLM3arQyB-mG19zz04G1X2D4J3W0XIEXJ6DasvOYbHA-_-Wk1JJ1Fbs6YlBt3HlIJjsPoWr3CVwxQ_T_-eQXJaag3A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69832940</pqid></control><display><type>article</type><title>Tumor growth inhibition and regression induced by photothermal vascular targeting and angiogenesis inhibitor retinoic acid</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>McMillan, Kathleen ; Perepelitsyn, Ilya ; Wang, Zhi ; Shapshay, Stanley M.</creator><creatorcontrib>McMillan, Kathleen ; Perepelitsyn, Ilya ; Wang, Zhi ; Shapshay, Stanley M.</creatorcontrib><description>The effect of photothermal vascular targeting, alone and in combination with antiangiogenic therapy, was evaluated using tumors produced in mice by transplantation of KB cells. Tumor growth inhibition and regression followed vascular damage produced by pulsed dye laser (PDL) radiation. Administration of the antiangiogenic agent all- trans-retinoic acid (RA) was associated with smaller average tumor volumes in the presence and absence of PDL irradiation, but this effect was not statistically significant. The ability of PDL photothermal vascular targeting to cause regression of tumors without harming normal tissue may be a consequence of preferential damage to supplying vessels at the tumor periphery.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/S0304-3835(98)00339-5</identifier><identifier>PMID: 10376792</identifier><identifier>CODEN: CALEDQ</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Animals ; Antineoplastic agents ; Antineoplastic Agents - therapeutic use ; Biological and medical sciences ; Carcinoma, Squamous Cell - blood supply ; Carcinoma, Squamous Cell - drug therapy ; Carcinoma, Squamous Cell - surgery ; Combined Modality Therapy ; Combined treatments (chemotherapy of immunotherapy associated with an other treatment) ; Humans ; Laser Coagulation - methods ; Medical sciences ; Mice ; Mice, Nude ; Microvasculature, Pulsed dye laser ; Neovascularization, Pathologic - drug therapy ; Neovascularization, Pathologic - surgery ; Pharmacology. Drug treatments ; Squamous cell cancer ; Tretinoin - therapeutic use ; Tumor Cells, Cultured</subject><ispartof>Cancer letters, 1999-03, Vol.137 (1), p.35-44</ispartof><rights>1999</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-458e61a68f95b04821d4eda8b5017e36863601e9f25e8f7e1cebf24669f225cc3</citedby><cites>FETCH-LOGICAL-c390t-458e61a68f95b04821d4eda8b5017e36863601e9f25e8f7e1cebf24669f225cc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0304-3835(98)00339-5$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1779734$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10376792$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McMillan, Kathleen</creatorcontrib><creatorcontrib>Perepelitsyn, Ilya</creatorcontrib><creatorcontrib>Wang, Zhi</creatorcontrib><creatorcontrib>Shapshay, Stanley M.</creatorcontrib><title>Tumor growth inhibition and regression induced by photothermal vascular targeting and angiogenesis inhibitor retinoic acid</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>The effect of photothermal vascular targeting, alone and in combination with antiangiogenic therapy, was evaluated using tumors produced in mice by transplantation of KB cells. Tumor growth inhibition and regression followed vascular damage produced by pulsed dye laser (PDL) radiation. Administration of the antiangiogenic agent all- trans-retinoic acid (RA) was associated with smaller average tumor volumes in the presence and absence of PDL irradiation, but this effect was not statistically significant. The ability of PDL photothermal vascular targeting to cause regression of tumors without harming normal tissue may be a consequence of preferential damage to supplying vessels at the tumor periphery.</description><subject>Animals</subject><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Squamous Cell - blood supply</subject><subject>Carcinoma, Squamous Cell - drug therapy</subject><subject>Carcinoma, Squamous Cell - surgery</subject><subject>Combined Modality Therapy</subject><subject>Combined treatments (chemotherapy of immunotherapy associated with an other treatment)</subject><subject>Humans</subject><subject>Laser Coagulation - methods</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Microvasculature, Pulsed dye laser</subject><subject>Neovascularization, Pathologic - drug therapy</subject><subject>Neovascularization, Pathologic - surgery</subject><subject>Pharmacology. Drug treatments</subject><subject>Squamous cell cancer</subject><subject>Tretinoin - therapeutic use</subject><subject>Tumor Cells, Cultured</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEtv1TAQRi0EoreFnwDyAqGyCNhx_FpVqOIlVWJBWVuOM8k1SuyL7RSVX4_vg8eO1WhG55sZHYSeUfKaEirefCGMdA1TjF9q9YoQxnTDH6ANVbJtpFbkIdr8Qc7Qec7fCCG8k_wxOqOESSF1u0E_b9clJjyl-KNssQ9b3_viY8A2DDjBlCDnfevDsDoYcH-Pd9tYYtlCWuyM72x262wTLjZNUHyYDkkbJh8nCJB9_r21nkl7InqHrfPDE_RotHOGp6d6gb6-f3d7_bG5-fzh0_Xbm8YxTUrTcQWCWqFGzXvSqZYOHQxW9ZxQCUwowQShoMeWgxolUAf92HZC1EnLnWMX6OVx7y7F7yvkYhafHcyzDRDXbIRWrNUdqSA_gi7FnBOMZpf8YtO9ocTspZuDdLM3arQyB-mG19zz04G1X2D4J3W0XIEXJ6DasvOYbHA-_-Wk1JJ1Fbs6YlBt3HlIJjsPoWr3CVwxQ_T_-eQXJaag3A</recordid><startdate>19990322</startdate><enddate>19990322</enddate><creator>McMillan, Kathleen</creator><creator>Perepelitsyn, Ilya</creator><creator>Wang, Zhi</creator><creator>Shapshay, Stanley M.</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990322</creationdate><title>Tumor growth inhibition and regression induced by photothermal vascular targeting and angiogenesis inhibitor retinoic acid</title><author>McMillan, Kathleen ; Perepelitsyn, Ilya ; Wang, Zhi ; Shapshay, Stanley M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-458e61a68f95b04821d4eda8b5017e36863601e9f25e8f7e1cebf24669f225cc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Squamous Cell - blood supply</topic><topic>Carcinoma, Squamous Cell - drug therapy</topic><topic>Carcinoma, Squamous Cell - surgery</topic><topic>Combined Modality Therapy</topic><topic>Combined treatments (chemotherapy of immunotherapy associated with an other treatment)</topic><topic>Humans</topic><topic>Laser Coagulation - methods</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Microvasculature, Pulsed dye laser</topic><topic>Neovascularization, Pathologic - drug therapy</topic><topic>Neovascularization, Pathologic - surgery</topic><topic>Pharmacology. Drug treatments</topic><topic>Squamous cell cancer</topic><topic>Tretinoin - therapeutic use</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McMillan, Kathleen</creatorcontrib><creatorcontrib>Perepelitsyn, Ilya</creatorcontrib><creatorcontrib>Wang, Zhi</creatorcontrib><creatorcontrib>Shapshay, Stanley M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McMillan, Kathleen</au><au>Perepelitsyn, Ilya</au><au>Wang, Zhi</au><au>Shapshay, Stanley M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tumor growth inhibition and regression induced by photothermal vascular targeting and angiogenesis inhibitor retinoic acid</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>1999-03-22</date><risdate>1999</risdate><volume>137</volume><issue>1</issue><spage>35</spage><epage>44</epage><pages>35-44</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><coden>CALEDQ</coden><abstract>The effect of photothermal vascular targeting, alone and in combination with antiangiogenic therapy, was evaluated using tumors produced in mice by transplantation of KB cells. Tumor growth inhibition and regression followed vascular damage produced by pulsed dye laser (PDL) radiation. Administration of the antiangiogenic agent all- trans-retinoic acid (RA) was associated with smaller average tumor volumes in the presence and absence of PDL irradiation, but this effect was not statistically significant. The ability of PDL photothermal vascular targeting to cause regression of tumors without harming normal tissue may be a consequence of preferential damage to supplying vessels at the tumor periphery.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>10376792</pmid><doi>10.1016/S0304-3835(98)00339-5</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0304-3835
ispartof Cancer letters, 1999-03, Vol.137 (1), p.35-44
issn 0304-3835
1872-7980
language eng
recordid cdi_proquest_miscellaneous_69832940
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animals
Antineoplastic agents
Antineoplastic Agents - therapeutic use
Biological and medical sciences
Carcinoma, Squamous Cell - blood supply
Carcinoma, Squamous Cell - drug therapy
Carcinoma, Squamous Cell - surgery
Combined Modality Therapy
Combined treatments (chemotherapy of immunotherapy associated with an other treatment)
Humans
Laser Coagulation - methods
Medical sciences
Mice
Mice, Nude
Microvasculature, Pulsed dye laser
Neovascularization, Pathologic - drug therapy
Neovascularization, Pathologic - surgery
Pharmacology. Drug treatments
Squamous cell cancer
Tretinoin - therapeutic use
Tumor Cells, Cultured
title Tumor growth inhibition and regression induced by photothermal vascular targeting and angiogenesis inhibitor retinoic acid
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T18%3A45%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tumor%20growth%20inhibition%20and%20regression%20induced%20by%20photothermal%20vascular%20targeting%20and%20angiogenesis%20inhibitor%20retinoic%20acid&rft.jtitle=Cancer%20letters&rft.au=McMillan,%20Kathleen&rft.date=1999-03-22&rft.volume=137&rft.issue=1&rft.spage=35&rft.epage=44&rft.pages=35-44&rft.issn=0304-3835&rft.eissn=1872-7980&rft.coden=CALEDQ&rft_id=info:doi/10.1016/S0304-3835(98)00339-5&rft_dat=%3Cproquest_cross%3E69832940%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69832940&rft_id=info:pmid/10376792&rft_els_id=S0304383598003395&rfr_iscdi=true